DK1140031T3 - Farmaceutisk sammensætning til kontrolleret frigivelse med tilidinmesylat som aktivt stof - Google Patents
Farmaceutisk sammensætning til kontrolleret frigivelse med tilidinmesylat som aktivt stofInfo
- Publication number
- DK1140031T3 DK1140031T3 DK99967009T DK99967009T DK1140031T3 DK 1140031 T3 DK1140031 T3 DK 1140031T3 DK 99967009 T DK99967009 T DK 99967009T DK 99967009 T DK99967009 T DK 99967009T DK 1140031 T3 DK1140031 T3 DK 1140031T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- active substance
- controlled release
- tilidine mesylate
- mesylate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19859636A DE19859636A1 (de) | 1998-12-23 | 1998-12-23 | Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff |
| PCT/EP1999/010381 WO2000038656A1 (de) | 1998-12-23 | 1999-12-23 | Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1140031T3 true DK1140031T3 (da) | 2003-12-01 |
Family
ID=7892368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99967009T DK1140031T3 (da) | 1998-12-23 | 1999-12-23 | Farmaceutisk sammensætning til kontrolleret frigivelse med tilidinmesylat som aktivt stof |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6579536B1 (pt) |
| EP (1) | EP1140031B1 (pt) |
| JP (1) | JP2002533381A (pt) |
| AT (1) | ATE252377T1 (pt) |
| AU (1) | AU770293B2 (pt) |
| BR (1) | BR9916575A (pt) |
| CA (1) | CA2355891A1 (pt) |
| CZ (1) | CZ301628B6 (pt) |
| DE (2) | DE19859636A1 (pt) |
| DK (1) | DK1140031T3 (pt) |
| ES (1) | ES2207334T3 (pt) |
| HK (1) | HK1039273A1 (pt) |
| HU (1) | HUP0104647A3 (pt) |
| MX (1) | MXPA01006493A (pt) |
| NO (1) | NO320022B1 (pt) |
| NZ (1) | NZ512079A (pt) |
| PL (1) | PL199024B1 (pt) |
| PT (1) | PT1140031E (pt) |
| SK (1) | SK284901B6 (pt) |
| TR (1) | TR200101864T2 (pt) |
| WO (1) | WO2000038656A1 (pt) |
| ZA (1) | ZA200105040B (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1041987E (pt) | 1997-12-22 | 2006-07-31 | Euro Celtique Sa | Forma farmaceutica de dosagem oral, compreendendo uma combinacao de um agonista de opioide e naltrexona |
| US6375957B1 (en) | 1997-12-22 | 2002-04-23 | Euro-Celtique, S.A. | Opioid agonist/opioid antagonist/acetaminophen combinations |
| IL151058A0 (en) * | 2000-02-08 | 2003-04-10 | Euro Celtique Sa | Controlled-release compositions containing opioid agonist and antagonist |
| EP2092936B1 (en) * | 2000-02-08 | 2013-03-20 | Euro-Celtique S.A. | Tamper-resistant oral opioid agonist formulations |
| EP1387673B1 (en) | 2001-05-11 | 2010-12-29 | Endo Pharmaceuticals Inc. | Abuse-resistant controlled-release opioid dosage form |
| ES2733051T1 (es) | 2002-04-05 | 2019-11-27 | Euro Celtique Sa | Matriz para liberación sostenida, invariable e independiente de compuestos activos |
| JP4563642B2 (ja) * | 2002-05-31 | 2010-10-13 | ワトソン ラボラトリーズ、インコーポレイテッド | 医薬製剤 |
| DE10233108A1 (de) * | 2002-07-20 | 2004-01-29 | Krewel Meuselbach Gmbh | Retardiertes Schmerzmittel enthaltend Tilidin und ein Lichtschutzmittel |
| DE10250081A1 (de) * | 2002-10-25 | 2004-05-13 | Boehringer Ingelheim Vetmedica Gmbh | Wasserlösliche Meloxicam Granulate |
| EP1479381A1 (en) * | 2003-05-19 | 2004-11-24 | Euro-Celtique S.A. | Pharmaceutical dosage form comprising a solid solution |
| EP1604666A1 (en) | 2004-06-08 | 2005-12-14 | Euro-Celtique S.A. | Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD) |
| CN1988889A (zh) * | 2004-07-22 | 2007-06-27 | 株式会社太平洋 | 含托吡酯的缓释制剂及其制备方法 |
| EP1702558A1 (en) | 2005-02-28 | 2006-09-20 | Euro-Celtique S.A. | Method and device for the assessment of bowel function |
| US20070048373A1 (en) * | 2005-08-30 | 2007-03-01 | Cima Labs Inc. | Dried milled granulate and methods |
| EP2168945A1 (en) * | 2008-09-26 | 2010-03-31 | Hexal Ag | Crystalline forms of Tilidine Mesylate |
| WO2010099508A1 (en) | 2009-02-26 | 2010-09-02 | Theraquest Biosciences, Inc. | Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use |
| MY152279A (en) | 2009-03-10 | 2014-09-15 | Euro Celtique Sa | Immediate release pharmaceutical compositions comprising oxycodone and naloxone |
| MY183489A (en) | 2013-07-23 | 2021-02-22 | Euro Celtique Sa | A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation |
| EP3193845A1 (en) | 2014-09-19 | 2017-07-26 | The Procter and Gamble Company | Pulsed release phenylephrine dosage forms |
| US10278930B2 (en) | 2017-03-16 | 2019-05-07 | The Procter & Gamble Company | Method for relieving sinus congestion |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU71847A1 (pt) * | 1975-02-14 | 1977-01-05 | ||
| SK281041B6 (sk) * | 1992-10-26 | 2000-11-07 | G�decke Aktiengesellschaft | Tilidíndihydrogenortofosfát, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje |
| US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| DE19710008A1 (de) * | 1997-03-12 | 1998-09-17 | Basf Ag | Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung |
| DK1073625T3 (da) * | 1998-04-28 | 2003-09-29 | Hexal Ag | Tilidinmesylat, fremgangsmåder til dets fremstilling og et farmaceutisk præparat deraf |
-
1998
- 1998-12-23 DE DE19859636A patent/DE19859636A1/de not_active Ceased
-
1999
- 1999-12-23 CZ CZ20012167A patent/CZ301628B6/cs not_active IP Right Cessation
- 1999-12-23 AT AT99967009T patent/ATE252377T1/de active
- 1999-12-23 DE DE59907481T patent/DE59907481D1/de not_active Expired - Lifetime
- 1999-12-23 EP EP99967009A patent/EP1140031B1/de not_active Expired - Lifetime
- 1999-12-23 HU HU0104647A patent/HUP0104647A3/hu unknown
- 1999-12-23 AU AU22862/00A patent/AU770293B2/en not_active Ceased
- 1999-12-23 US US09/869,033 patent/US6579536B1/en not_active Expired - Fee Related
- 1999-12-23 SK SK892-2001A patent/SK284901B6/sk unknown
- 1999-12-23 JP JP2000590610A patent/JP2002533381A/ja active Pending
- 1999-12-23 DK DK99967009T patent/DK1140031T3/da active
- 1999-12-23 PL PL348419A patent/PL199024B1/pl not_active IP Right Cessation
- 1999-12-23 MX MXPA01006493A patent/MXPA01006493A/es not_active Application Discontinuation
- 1999-12-23 CA CA002355891A patent/CA2355891A1/en not_active Abandoned
- 1999-12-23 NZ NZ512079A patent/NZ512079A/en unknown
- 1999-12-23 ES ES99967009T patent/ES2207334T3/es not_active Expired - Lifetime
- 1999-12-23 WO PCT/EP1999/010381 patent/WO2000038656A1/de active IP Right Grant
- 1999-12-23 TR TR2001/01864T patent/TR200101864T2/xx unknown
- 1999-12-23 BR BR9916575-9A patent/BR9916575A/pt not_active IP Right Cessation
- 1999-12-23 PT PT99967009T patent/PT1140031E/pt unknown
-
2001
- 2001-06-20 NO NO20013060A patent/NO320022B1/no not_active IP Right Cessation
- 2001-06-20 ZA ZA200105040A patent/ZA200105040B/en unknown
- 2001-12-13 HK HK01108775A patent/HK1039273A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2207334T3 (es) | 2004-05-16 |
| BR9916575A (pt) | 2001-09-18 |
| NO20013060L (no) | 2001-06-20 |
| JP2002533381A (ja) | 2002-10-08 |
| DE59907481D1 (de) | 2003-11-27 |
| PT1140031E (pt) | 2004-03-31 |
| NO320022B1 (no) | 2005-10-10 |
| ATE252377T1 (de) | 2003-11-15 |
| NO20013060D0 (no) | 2001-06-20 |
| NZ512079A (en) | 2003-08-29 |
| CZ20012167A3 (cs) | 2001-11-14 |
| CA2355891A1 (en) | 2000-07-06 |
| US6579536B1 (en) | 2003-06-17 |
| SK8922001A3 (en) | 2001-12-03 |
| HUP0104647A3 (en) | 2003-12-29 |
| CZ301628B6 (cs) | 2010-05-05 |
| EP1140031A1 (de) | 2001-10-10 |
| PL348419A1 (en) | 2002-05-20 |
| MXPA01006493A (es) | 2002-06-04 |
| HUP0104647A2 (hu) | 2002-03-28 |
| EP1140031B1 (de) | 2003-10-22 |
| AU770293B2 (en) | 2004-02-19 |
| WO2000038656A1 (de) | 2000-07-06 |
| TR200101864T2 (tr) | 2002-01-21 |
| AU2286200A (en) | 2000-07-31 |
| DE19859636A1 (de) | 2000-06-29 |
| SK284901B6 (sk) | 2006-02-02 |
| ZA200105040B (en) | 2002-05-22 |
| HK1039273A1 (en) | 2002-04-19 |
| PL199024B1 (pl) | 2008-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1140031T3 (da) | Farmaceutisk sammensætning til kontrolleret frigivelse med tilidinmesylat som aktivt stof | |
| NO971206D0 (no) | Forlenget-frigjöringsformulering | |
| BR0306870A (pt) | Composição farmacêutica oral, e, método para preparar a mesma | |
| TR200100931T2 (tr) | Yeni sürekli salınımlı oral formülasyonlar | |
| HUP0101237A1 (hu) | Elnyújtott kioldódású gyógyszerkészítmények | |
| NO20011721D0 (no) | N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor | |
| BRPI0015567B8 (pt) | composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica | |
| DK200000390U1 (da) | Farmaceutiske præparater til oral indgivelse, der omfatter paroxetin-methansulfonat. | |
| EA200000584A2 (ru) | Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием | |
| ATE302616T1 (de) | Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe | |
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| MY151468A (en) | Controlled release solid preparation | |
| BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
| DE60205870D1 (de) | Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil | |
| NO20064808L (no) | Orale matrixformuleringer med licarbazepin | |
| DK1121127T3 (da) | Orale farmaceutiske sammensætninger, som indeholder buprenorphin | |
| DK1185253T3 (da) | Oralt præparat til indgivelse af en fast kombination af tramadol og diclofenac | |
| NO20045385L (no) | Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff | |
| DK1105105T3 (da) | Oral administrationsform til pyridin-2-ylmethylsulfinyl-1H-benzimidazoler | |
| NO20064783L (no) | Opplosningstabeletter med licarbazepin | |
| NO20014855D0 (no) | N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister | |
| BR0114395A (pt) | Composição farmacêutica para administração por suprimento via oral | |
| TR200200683T2 (tr) | Oral kontrollü salıverme formülasyonları. | |
| DK0469440T3 (da) | Faste orale applikationsformer, der som aktivt stof indeholder ifosamid | |
| EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение |